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In contrast to mast cells and basophils, the high-
af®nity IgE receptor (FceRI) on monocytes and den-
dritic cells (DC), including epidermal Langerhans
cells, is not constitutively expressed and lacks the
b-chain. FceRI is upregulated on Langerhans cells of
atopic individuals, particularly in atopic dermatitis
skin. Although FceRI provides IgE-mediated antigen
focusing on monocytes and DC/Langerhans cells, its
relevance for cell activation remains elusive, and the
transcription factors regulating FceRI-induced genes
are unknown. We show that NF-kB, known to regu-
late genes essential for in¯ammatory responses and
DC differentiation and function, is activated upon
FceRI ligation in primary human monocytes and
DC. In Langerhans cells isolated from epidermis,
NF-kB activation is restricted to donors expressing
high FceRI amounts. FceRI-induced NF-kB com-
plexes in monocytes and DC contain p50 and p65,
but no other NF-kB subunits despite increased RelB
expression during differentiation. NF-kB activation
is preceded by serine phosphorylation and degrad-
ation of its inhibitory protein IkB-a without involv-
ing other IkB proteins. Finally, we show that FceRI
ligation on monocytes and DC leads to synthesis and
release of tumor necrosis factor-a and monocyte
chemoattractant protein-1, which is decreased by
two mechanistically distinct inhibitors of NF-kB
activation. Thus NF-kB activation represents a novel
mechanism by which FceRI on monocytes and DC
potentially controls in¯ammatory reactions. Key
words: atopy/dendritic cells/IgE receptor/in¯ammation/
NF-kB. J Invest Dermatol 118:830±837, 2002
A
mong professional antigen-presenting cells (APC),
dendritic cells (DC) show the unique capacity to
initiate primary immune responses (Banchereau and
Steinman, 1998). Immature DC form the outposts of
the immune system in peripheral tissues and are
characterized by their high antigen uptaking capacity. Upon
various stimuli, they differentiate into highly stimulatory mature
DC. The prototype of immature DC are Langerhans cells, which as
epidermal sentinels take part in host defense or in pathologic
conditions like allergic contact dermatitis. The study of DC
functions has been facilitated since the in vitro generation of DC
from peripheral monocytes by culture with GM-CSF and IL-4 has
been reported (Sallusto and Lanzavecchia, 1994).
Langerhans cells, blood DC, and monocytes variably express a
trimeric form of the high-af®nity receptor for IgE (FceRI)
containing one a- and two g-chains, but lack the b-chain
characteristic for tetrameric FceRI on mast cells and basophils
(Bieber et al, 1992; Wang et al, 1992; Maurer et al, 1994, 1996;
Kinet, 1999). In contrast to the latter, there is ample evidence that
FceRI+ APC are involved in IgE-mediated delayed-type hyper-
sensitivity reactions in atopic diseases: First, FceRI surface expres-
sion on Langerhans cells is enhanced in patients with atopic
dermatitis (AD) (Bieber, 1997). Second, Langerhans cells/DC and
monocytes can take up, process, and present antigens to T cells
more ef®ciently using FceRI (Mudde et al, 1990; Maurer et al,
1995, 1996).
Nuclear factor-kB (NF-kB) family transcription factors are
DNA-binding dimers consisting of p50, p52, p65, RelB, and/or
c-Rel subunits and play a pivotal role in the regulation of gene
expression (Baeuerle and Henkel, 1994; Ghosh et al, 1998). A wide
range of stimuli lead to NF-kB-mediated activation of target genes
involved in acute-phase responses, in¯ammation, or cell growth
and differentiation, e.g., MHC molecules, adhesion molecules,
cytokines, and chemokines. Inactive NF-kB is retained by
inhibitory IkB molecules in the cytoplasm and, upon stimulation,
undergoes serine phosphorylation by the IkB kinase (IKK) complex
followed by its proteasomal degradation (Karin and Ben-Neriah,
2000). Mature DC constitutively express high levels of NF-kB
subunits with RelB required for differentiation of myeloid DC and
possibly relevant for antigen presentation (Burkly et al, 1995; Pettit
et al, 1997; Banchereau and Steinman, 1998; Wu et al, 1998).
FceRI signal transduction pathways have been explored in mast
cells and basophils with a major FceRI-induced regulator being
NF-AT (Hutchinson and McCloskey, 1995; Prieschl et al, 1995;
Turner et al, 1995), while the induction of a complex binding to
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NF-kB sites, but containing unknown proteins different from
members of the NF-kB family, has been described (Pelletier et al,
1998; Marquardt and Walker, 2000). As a result of FceRI ligation
on these cells, the release of histamine, production of eicosanoids,
proin¯ammatory cytokines and Th2 cytokines are induced
(Gordon et al, 1990; Razin et al, 1983; Lorentz et al, 2000).
FceRI on APC, however, lacks the b-subunit, which plays a
crucial role in signal transduction in mast cells and basophils. In
addition, FceRI-bearing APC are proposed to exert a different
functional role, i.e., in antigen focusing, and may activate different
genes upon FceRI ligation. Thus, it is not clear whether FceRI in
these cells involves similar pathways as in effector cells of
anaphylaxis. We have previously reported that cross-linking of
FceRI on Langerhans cells leads to rapid tyrosine phosphorylation
of several proteins and only Langerhans cells from patients with AD
show calcium mobilization (JuÈrgens et al, 1995). Later events in
FceRI signaling, like transcription factor activation, are unknown
in APC.
In this study we asked whether FceRI ligation on primary
human monocytes, monocyte-derived DC (MoDC), and epider-
mal Langerhans cells leads to the activation of NF-kB and how NF-
kB complexes are composed. In addition, we investigated the
pathways leading to NF-kB activation and analyzed the expression
of genes mediated by FceRI and NF-kB.
MATERIALS AND METHODS
Reagents PE-labeled T6/RD1 (Coultertronics, Krefeld, Germany),
BL6 (Immunotech, Marseille, France) mouse monoclonal antibody
(MoAb) recognizes CD1a. Rabbit anti-human IgE was from DAKO
(Glostrup, Denmark). Human myeloma IgE was obtained from
Calbiochem (San Diego, CA). The MoAb 22E7 (a kind gift from Dr. R.
Chizzonite, Roche, Nutley, NJ) and CRA1 (kindly provided by Dr. C.
Ra, Juntendo University School of Medicine, Tokyo, Japan) recognize
the FceRI a-subunit. MoAb speci®c for FceRII/CD23 were clones
MHM6 (DAKO) and 9P.25 (Jackson, West Grove, PA). FITC-labeled
F(ab¢)2 fragments of goat anti-mouse were also purchased from Jackson.
FITC- or PE-labeled anti-CD14, PE-labeled anti-CD-117, and mouse
IgG1 were from BD (Mountain View, CA) and PE-labeled anti-203c
was from Immunotech. Sheep anti-mouse coated magnetic beads
(M-280) were from Dynal (Oslo, Norway). VLE RPMI 1640 medium
was from Biochrom (Berlin, FRG). Antibodies against IkB and NF-kB
subunits were from Santa Cruz (Santa Cruz, CA). Phospho-IkB-a
antibody was purchased from New England Biolabs (Beverly, MA). PE-
labeled MoAb against tumor necrosis factor-a (TNF-a), monocyte
chemoattractant protein-1 (MCP-1), isotype controls, and GolgiPlug
(Brefeldin A) were from Pharmingen (San Diego, CA). All other
chemicals were from Sigma unless otherwise indicated.
Preparation of epidermal cell suspensions and Langerhans cells
Skin specimens were obtained from our surgery department. Written
informed consent was obtained from all donors. Epidermal cell (EC)
suspensions were prepared as described in Bieber et al (1992). Then EC
were puri®ed by positive selection with anti-CD1a bound magnetic
beads according to the manufacturer's protocol. The purity of the
Langerhans cell preparations was controlled by microscopy, and the
procedure was stopped when unbound cells were completely removed
(> 98% Langerhans cells).
Monocyte isolation and generation of MoDC Monocytes were
isolated from peripheral blood with a modi®ed density gradient protocol
using Nycoprep (Nycomed, Oslo, Norway) according to the
manufacturer's instructions. Brie¯y, erythrocytes were sedimented from
whole EDTA blood with 1/10 (wt/vol) 6% Dextran 500 in 0.9% NaCl.
Plasma was gently layered over Nycoprep and centrifuged for 20 min at
600 3 g. After separation, the interphase and Nycoprep were collected
and washed four times with 0.9% NaCl + 0.13% EDTA + 1% BSA.
The purity of the isolated monocytes in a typical experiment was 94%
CD14+ cells, 2.4% CD56+ cells, 0.25% CD3+ CD4+ cells, 0.27%
CD3+ CD8+ cells, 1.72% CD83+ cells, 0.03% CD19+ cells. Then,
monocytes were used for experiments or cultured for 4±8 d in RPMI
1640 + 10% fetal calf serum + 1% L-glutamine + 1% antibiotics/
antimycotics + 500 U GM-CSF per ml (Genzyme, Cambridge,
MA) + 500 U IL-4 per ml (Life Technologies) to yield immature
MoDC. Final maturation was achieved by incubation with TNF-a
(100 IU per ml) for 2 d.
Flow cytometric analysis of FceRI, FceRII, and intracellular RelB
expression Labeling for FceRI was performed as previously reported
in Bieber et al (1992). Brie¯y, EC were washed with PBS + 0.5% fetal
calf serum + 0.1% NaN3 followed by incubation with anti-FceRIa
MoAb 22E7, anti-FceRII/CD23 MoAb 9P.25, or isotype control. After
washing, EC were stained with FITC-conjugated secondary antibody,
washed again, and blocked with 5% mouse serum. Finally, staining
against CD1a (Langerhans cells or MoDC) or CD14 (monocytes) was
performed using PE-labeled antibodies. Acquisition and analyzes were
performed on a FACScalibur ¯ow cytometer (BD). CD1a-negative and
dead cells (determined by 7-amino-actinomycin D uptake) were gated
out manually. Flow cytometric staining of intracellular RelB in saponin-
permeabilized cells using a rabbit polyclonal antibody followed by
staining with a FITC-conjugated donkey anti-rabbit (Jackson) and PE-
conjugated anti-CD14 or anti-CD1a antibodies was performed as
described in Wollenberg et al (1996).
FceRI ligation Cross-linking of FceRI was done with IgE/anti-IgE as
previously described (JuÈrgens et al, 1995). Monocytes, MoDC, and
Langerhans cells were tested for their FceRI, FceRII/CD23, and CD14/
CD1a expression. Then, cells were incubated for 60 min with 5 mg
monomeric IgE per ml at 37°C (monocytes were allowed to adhere for
3 h before stimulation). After washing with culture medium, 20 mg
rabbit anti-human IgE per ml was added and cells were incubated for an
adequate period of time for subsequent ELISA, ¯ow cytometric staining,
or lysis. For ¯ow cytometric determination of cytokine synthesis,
GolgiPlug (brefeldin A) was added to the culture. When indicated, NAC
(n-acetylcystein) (30 mM) or TPCK (n-tosyl-L-phenylalanin-chloro-
methyl-ketone) (5 mM) were added to inhibit NF-kB activation. For
EMSA and IkB degradation experiments, cells were incubated with
0.5 U neuraminidase per ml followed by 0.02 M lactose to enhance IgE
binding to FceRI before stimulation (Wollenberg et al, 1993; Reischl
et al, 1996). Alternatively, speci®c stimulation of IgE receptors was
achieved with the anti-FceRI MoAb 22E7 or CRA1, anti-FceRII/
CD23 MoAb MHM6 or isotype control (10 mg per ml) or TNF-a as
positive control (100 U per ml).
Detection of cytokine expression Production of TNF-a or MCP-1
by monocytes was assessed by intracellular staining and ELISA.
Intracellular staining was performed with the Cyto®x/Cytoperm kit
(Pharmingen) according to the manufacturer's instructions. Then, the
cells were analyzed on a FACScalibur ¯ow cytometer (BD). RFI
(relative ¯uorescence index) values were calculated using MFI (mean
¯uorescence index) values as follows:
RFI  MFI specific ÿMFI isotype control
MFI isotype control :
For determination of released cytokines, ELISA from Bender Medical
Systems (Vienna, Austria) for TNF-a and R&D Systems (Minneapolis,
MN) for MCP-1 were used according to the manufacturer's instructions.
Immunoblotting of NF-kB and IkB molecules After lysis with
10 mM Tris + 10 mM MgCl2 + 1% Triton X-100 in the presence of
protease inhibitors, the samples were centrifuged at 12 000 3 g.
Supernatants were collected and boiled after adding 25% 5 3 Laemmli
buffer. For determination of IkB-a phosphorylation, cells were lysed
directly in Laemmli buffer. Samples were fractionated by SDS-PAGE
and electrotransferred to nitrocellulose membranes. After blocking,
proteins were identi®ed using NF-kB and IkB antibodies. The bands
were visualized with peroxidase-conjugated secondary antibodies
followed by an enhanced chemiluminescence detection protocol
(Amersham, IL).
Electrophoretic mobility shift assays (EMSA) Cells were lysed with
10 mM Tris/HCl pH 7.5, 50 mM NaCl, 50 mM NaF, 5 mM ZnCl2,
1% Triton X-100, and 0.5 mM phenymethylsulfonyl ¯uoride. After
centrifugation at 14 000 3 g, the supernatants were subjected to binding
reactions (total volume 20 ml) in 10 mM Hepes pH 7.2, 40 mM KCl,
0.05 mM EDTA, 0.025% NP-40, 4% Ficoll 400, 2% glycerol, 1 mg BSA
per ml, 25 ng poly(dL-dC) per ml, 1 mM dithiothreitol, 0.05 mM
phenymethylsulfonyl ¯uoride, and 20 000 cpm of a 32P-labeled double-
stranded NF-kB consensus oligonucleotide (Promega, Madison, WI) for
25 min at room temperature. Labeling of the oligonucleotide was
performed with a T4 polynucleotide kinase kit (New England Biolabs).
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For supershifts, lysates were incubated with 200 mg per ml of NF-kB-
speci®c antibodies (Santa Cruz) for 1 h on ice, followed by 25 min of
incubation with the oligonucleotide. DNA-protein complexes were
separated from unbound DNA probe on 4.5% polyacrylamide gels.
NF-kB oligonucleotide sequence:
5¢-AGTTGAGGGGACTTTCCCAGGC-3¢
3¢-TCAACTCCCCTGAAAGGGTCCG-5¢
Statistical analysis Statistical analysis using Wilcoxons' test was
performed with SPSS 9.0 for Windows (SPSS, Chicago, IL). Calculated
values shown were mean 6 standard error of mean (SEM).
RESULTS
Identi®cation of NF-kB subunits expressed in monocytes
and MoDC NF-kB transcription factors are essential for DC
differentiation and APC functions (Burkly et al, 1995; Pettit et al,
1997; Rescigno et al, 1998; Wu et al, 1998). To determine if NF-
kB is expressed in our system, we analyzed p50, p52, p65, RelB,
and c-Rel expression using monocytes, immature, and mature
MoDC. Peripheral monocytes were isolated at high purity (>85%)
using a modi®ed density gradient protocol avoiding adhesion of
cells prior to isolation. Immature MoDC were obtained after
culture with GM-CSF and IL-4. In addition, we used TNF-a to
induce further maturation of DC. Contamination of the monocyte
and DC preparations with effector cells of anaphylaxis such as mast
cells and basophils was excluded by staining with anti-CD117
(c-kit) and anti-CD203c (ectonucleotide pyrophosphatase/
phosphodiesterase-3) antibodies. We found all ®ve subunits to be
expressed during the differentiation stages observed (Fig 1A). In
addition, we detected higher c-Rel levels at both MoDC stages
compared with monocytes and a continuous upregulation of RelB
during differentiation, which was con®rmed by ¯ow cytometric
analysis of permeabilized cells (Fig 1B). This is in accordance with
its formerly described essential role in DC development and antigen
presentation and recently published data using DC generated from
adherent monocytes (Neumann et al, 2000).
Cross-linking of FceRI induces DNA binding of NF-kB in
monocytes and MoDC Because of the prominent expression of
NF-kB subunits in primary human APC and NF-kB's role in the
regulation of genes relevant for in¯ammatory processes (Baeuerle
and Henkel, 1994; Ghosh et al, 1998), we looked for its activation
following cross-linking of FceRI-bound IgE by anti-IgE anti-
bodies. Monocytes from our donor group (n = 5) expressed
signi®cant amounts of FceRI (24.90% 6 2.99%; mean 6 SEM)
and no or very low low-af®nity IgE receptor FceRII/CD23
(4.20% 6 3.69%), whereas MoDC were consistently positive for
both FceRI (21.05% 6 10.34%) and FceRII/CD23 (84.54% 6
4.19%). Cross-linking of FceRI via IgE/anti-IgE induced a strong
activation of NF-kB DNA-binding activity (Fig 2A). Whereas in
monocytes the activation peaked after 60 min, the maximum was
reached after 10 min in MoDC. TNF-a, a known inducer of NF-
kB used as a positive control, reached approximately the same level
of activation after 30 min of stimulation. To compare our results
with effector cells of anaphylaxis bearing tetrameric FceRI, we
performed control experiments with RBL-48 cells transfected with
human FceRIa (Gil®llan et al, 1992). Stimulation with IgE/anti-
IgE similarly resulted in a DNA-binding NF-kB complex (data not
shown).
Because the low-af®nity IgG receptor CD32 is present both on
monocytes and on MoDC (Pickl et al, 1996), stimulation via IgE/
anti-IgE might theoretically also activate pathways mediated by this
receptor. To con®rm that the NF-kB induction observed is indeed
mediated by FceRI, we used two different MoAb speci®c for
FceRI for stimulation, compared with an irrelevant IgG1 isotype
control. Figure 2(B) shows that FceRI is able to induce NF-kB
activation in the cell types investigated. From these experiments we
conclude that FceRI cross-linking activates NF-kB in APC.
FceRI ligation activates NF-kB in human epidermal
Langerhans cells with high FceRI expression Having
determined that NF-kB is a mediator of FceRI-derived signals in
in vitro generated immature DC, we then analyzed epidermal
FceRI+ Langerhans cells, which are assumed to play a key role in
AD. Therefore, Langerhans cells were freshly isolated from normal
looking human skin, puri®ed, and stimulated with IgE/anti-IgE
followed by determination of NF-kB DNA binding. They did not
express the low-af®nity receptor FceRII/CD23 but displayed
various levels of FceRI, as determined by ¯ow cytometry (n = 6).
Langerhans cells expressing low but signi®cant amounts of FceRI
Figure 1. Expression of NF-kB subunits
during human DC differentiation. Monocytes,
MoDC, and mature DC were generated as
described in Materials and Methods. (A) Immuno-
blotting was performed using antibodies speci®c
for NF-kB subunits. (B) Flow cytometric data
were obtained after permeabilization with saponin
and double staining with anti-RelB followed by a
FITC-labeled secondary antibody and a PE-
labeled anti-CD14 or anti-CD1a antibody for
monocytes or DC, respectively.
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(18.5% 6 2.8%; n = 3) did not show any activation of NF-kB in
EMSA after activation with anti-IgE-antibody (Fig 3, lower panel).
In contrast, in Langerhans cells with high amounts of FceRI
(56.7% 6 16.0%; n = 3), a strong induction of NF-kB DNA
binding could be observed after activation under the same
conditions (Fig 3, upper panel). From these experiments we
conclude that FceRI induces NF-kB DNA binding in freshly
isolated human epidermal Langerhans cells, i.e., immature DC
isolated ex vivo, provided that they substantially express the high-
af®nity IgE receptor.
The NF-kB complex activated in monocytes and MoDC
contains p50 and p65 subunits Because NF-kB complexes can
be composed of various homo- and heterodimers potentially
targeting different genes, we analyzed the NF-kB subunits induced
by IgE/anti-IgE stimulation in monocytes and DC by supershift
assays using antibodies speci®c for NF-kB subunits. In monocytes
and MoDC p50-speci®c antibodies produced a retarded band and
p65-speci®c inhibitory antibodies directed against the DNA-
binding domain abrogated the NF-kB complex (Figs 4A, B);
however, despite signi®cant expression of c-rel and even
upregulated levels of RelB (Fig 1) in MoDC, none of these
factors could be detected in the FceRI-induced complexes in
MoDC. p52 was also not detected in any NF-kB complex activated
by FceRI (data not shown). Taken together, these data imply that
FceRI on APC activates complexes containing the most abundant
p50 and p65 subunits.
FceRI-mediated NF-kB activation in APC occurs by serine
phosphorylation of IkB-a Two different activation pathways
for NF-kB have been described so far. In the best-characterized
pathway IkB-a is phosphorylated at Ser32/36 and becomes
subsequently degraded via the ubiquitin-proteasome pathway
(Karin and Ben-Neriah, 2000). Degradation of other IkB family
members like IkB-b has also been shown to lead to NF-kB
activation (Ghosh et al, 1998). In the second, alternative pathway
IkB-a is phosphorylated at Tyr42 and releases NF-kB without
being degraded (Imbert et al, 1996). In a ®rst approach, by
immunoblotting with speci®c antibodies we could detect the
expression of IkB-a, IkB-b, and IkB-e, but not IkB-g in
monocytes and MoDC (data not shown). Then immunoblots
using lysates from monocytes and MoDC stimulated via FceRI
were analyzed with an antibody speci®cally recognizing
phosphorylated Ser32 of IkB-a. Ser32 was phosphorylated 2 min
following stimulation and the signal lasted for up to 20 min
(Fig 5A). IkB-a was almost completely degraded after 30 min
stimulation (Fig 5B); however, no degradation of IkB-b was
observed even after a stimulation period of 120 min (Fig 5C).
Thus, we conclude that FceRI induces NF-kB via serine
phosphorylation and subsequent degradation of IkB-a.
FceRI-induced NF-kB activation leads to the synthesis and
secretion of TNF-a and MCP-1 To our knowledge, the only
known FceRI-induced genes in monocytes are TNF-a, Bcl-2
family proteins, and IL-12 (Katoh et al, 2000), whereas in MoDC
no data are available. Because the NF-kB-mediated induction of
genes involved in immune reactions may represent a link between
FceRI and effector functions of APC, we tested the hypothesis that
NF-kB activation via FceRI leads to de novo production of NF-kB
regulated cytokines and chemokines known to play a pivotal role in
in¯ammatory processes. First, we investigated whether intracellular
TNF-a and MCP-1 synthesis was induced by FceRI ligation on
monocytes and whether their induction was suppressed by NF-kB
inhibition. As transfection of human APC can only be done
suf®ciently using adenoviral vectors and as this has been reported to
induce NF-kB activation and DC maturation (Morelli et al, 2000),
it was not desirable to apply molecular inhibition strategies. As an
alternative, we used two mechanistically distinct compounds that
have been reported to suppress NF-kB-activating pathways, the
antioxidant NAC or the proteasome inhibitor TPCK (Staal et al,
1990; Kim et al, 1995). Table I shows a signi®cant upregulation of
both TNF-a and MCP-1 synthesis by FceRI ligation, which was
suppressed by both NAC and TPCK, determined by intracellular
¯ow cytometry of permeabilized monocytes.
To ascertain these ®ndings, we tested whether FceRI- and NF-
kB-induced MCP-1 and TNF-a production leads to their release.
For this purpose, the supernatants of unstimulated monocytes and
MoDC were compared with those from IgE/anti-IgE-stimulated
cells with or without the addition of NAC and TPCK. As shown in
Fig 6, TNF-a and MCP-1 production was enhanced by FceRI
ligation on monocytes and MoDC but suppressed by NAC and
TPCK. FceRI-mediated TNF-a and MCP-1 secretion was
suppressed by NAC and TPCK. Taken together, these data
demonstrate that FceRI-mediated NF-kB activation in APC may
represent a mechanism to control the expression of target genes
involved in in¯ammatory processes.
DISCUSSION
With regard to the lack of data concerning the signal transduction
pathway induced by FceRI ligation in human APC and the
pathophysiologic role assumed to be played by these cells in allergic
reactions, this study was designed to explore whether FceRI
induces the NF-kB activation pathway in APC. Here we could
show that (i) all NF-kB subunits are expressed during the
differentiation stages from monocytes toward DC with continuous
upregulation of RelB expression; (ii) FceRI ligation induces the
activation of NF-kB complexes containing p50 and p65 in APC;
(iii) FceRI ligation induces NF-kB activation only in freshly
isolated Langerhans cells from atopic individuals, i.e., with high
receptor expression; (iv) NF-kB activation is mediated by serine
phosphorylation and degradation of IkB-a; and (v) FceRI-induced
production of TNF-a and MCP-1 in APC is dependent on NF-kB
activation.
Figure 2. FceRI ligation induces NF-kB DNA binding in
monocytes and MoDC. (A) Cells were loaded with IgE and stimulated
as described in Materials and Methods. TNF-a was used as a positive
control. For EMSA assays, cell lysis and incubation with a 32P-labeled
oligonucleotide representing a conserved NF-kB binding sequence were
performed. Electrophoretic separation of the DNA/protein-complexes
was followed by autoradiography. The arrows indicate the retarded
complexes representing NF-kB proteins bound to the labeled
oligonucleotide. The data shown are representative for six experiments.
(B) EMSA assays showing NF-kB induction using MoAb stimulation
against FceRI (10 mg per ml) for 60 min. The data shown are
representative for three experiments.
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We found all NF-kB subunits expressed during the differenti-
ation stages from monocytes towards DC, whereas p50, p52, and
p65 did not show any signi®cant differences. In contrast,
continuous upregulation of RelB was observed con®rming a
recent report using a different protocol for monocyte isolation and
DC culture (Neumann et al, 2000). Similarly, c-Rel is upregulated
during the generation of MoDC, which is in line with ®ndings on
c-Rel in lymphocyte precursor cells (Huguet et al, 1998) and
maturing DC (Neumann et al, 2000). As it is assumed that MoDC
are representative for immature DC in peripheral tissues in vivo, the
strong expression of RelB and c-Rel would witness this maturation
at the molecular level.
Whereas NF-AT represents the major transcription factor
activated by FceRI ligation on effector cells of anaphylaxis
(Hutchinson and McCloskey, 1995; Prieschl et al, 1995; Turner
and Cantrell, 1997), studies on murine mast cells have recently
identi®ed a weak NF-kB activation induced by FceRI ligation
(Marquardt and Walker, 2000). Another report (Pelletier et al,
1998) using RBL-2H3 cells suggested that FceRI-induced TNF-a
upregulation is mediated by an NF-kB-like complex containing
unknown subunits. The subunits forming the FceRI-induced NF-
kB complex may differ between cell and tissue types. This may be
due to different functions and, as a prerequisite, different genes
activated in these cells. In mast cells a NF-kB complex of unknown
subunits is induced, whereas our experiments using monocytes are
the ®rst to show that FceRI indeed can induce a complex
containing the known NF-kB subunits p50 and p65. Surprisingly,
the complex observed in MoDC also contained only p50 and p65
but lacked p52, RelB, and c-Rel. Keeping in mind the essential
function of the RelB subunit in myeloid DC differentiation
Figure 4. The FceRI-induced NF-kB complex in monocytes and
MoDC contains p50 and p65 subunits. Monocytes (A) and MoDC
(B) were loaded with IgE, washed, and then stimulated with anti-IgE
antibody for 30 min. For supershift analyzes, lysates were incubated with
antibodies speci®c for NF-kB subunits. This was followed by incubation
with a 32P-labeled oligonucleotide speci®c for NF-kB. DNA/protein-
complexes were separated by polyacrylamide gel electrophoresis and
detected by autoradiography. NF-kB subunits were identi®ed by further
retardation of bands (p50) or competition of NF-kB DNA binding (p65,
RelB, c-Rel) caused by the addition of speci®c antibodies.
Figure 3. NF-kB induction in human
Langerhans cells is restricted to FceRIhigh
Langerhans cells. FceRI expression was
monitored by ¯ow cytometry as described in
Materials and Methods (see histograms on the left
side). Puri®ed Langerhans cells were stimulated
with IgE/anti-IgE and EMSA assays were
performed as described in Fig 2.
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(Burkly et al, 1995; Banchereau and Steinman, 1998; Wu et al,
1998) and the consistent upregulation we observed during DC
differentiation (Fig 1), this observation raises further questions.
First, it is not known whether this holds for other DC, e.g.,
epidermal Langerhans cells. Second, stimulation of human mono-
cytes with LPS, TNF-a, or calcium ionophore has been reported
to induce differentiation via NF-kB activation containing RelB
subunits (Lyakh et al, 2000). Hence, the lack of RelB induction by
FceRI on monocytes and DC may prevent terminal maturation of
DC, or maturation may be dependent on additional in¯ammatory
signals, e.g., autocrine or external production of proin¯ammatory
cytokines like TNF-a.
Our recent observations showing that FceRI cross-linking on
monocytes and its monovalent ligation by IgE can prevent
apoptosis by means of TNF-a and Bcl-2 family protein upregula-
tion (Katoh et al, 2000) are in line with this study because NF-kB
activation can provide antiapoptotic signals (Van Antwerp et al,
1996) and represents a regulatory transcription factor for the genes
mentioned above. Recently, prevention of apoptosis by IgE has
also been shown for mast cells (Asai et al, 2001; Kalesnikoff et al,
2001). The mechanism underlying these events is unclear. While
Asai et al found no signaling events and no upregulation of Bcl-2
family proteins induced by monovalent IgE, Kalesnikoff et al
found activation of Erk, JNK, p38, and PKB as well as Bcl-Xl
upregulation. NF-kB would also be a candidate transcription factor
to be involved in that mechanism, as it is known to regulate Bcl-Xl
expression (Khoshnan et al, 2000); however, in our system using
IgE as a stimulus for monocytes and DC we could ®nd no
signi®cant NF-kB activation.
In addition, because we have shown recently that FceRI ligation
on human monocytes induces IL-12 release (Katoh et al, 2000), we
speculate that APC-derived IL-12 production could play a role in
the switch from a Th2 towards a Th1 phenotype observed during
the chroni®cation of AD lesions (Grewe et al, 1998). Using freshly
isolated human Langerhans cells as paradigmatic immature DC, we
showed that NF-kB activation occurs only in cells from donors
with high FceRI expression. This con®rms our observations that
FceRI-induced calcium mobilization exists only in Langerhans cells
from atopic donors showing high FceRI expression (JuÈrgens et al,
1995). Thus in vivo FceRI-mediated NF-kB activation may only
occur in atopic individuals, in addition to antigen focusing,
providing a second signal via upregulation of in¯ammatory
mediators.
Ten et al (1999) reported about NF-kB induction by FceRII/
CD23 on monocytic cell lines and monocytes treated with IL-4 in
order to express FceRII/CD23. We also detected NF-kB induc-
tion by CD23 stimulation with monoclonal antibodies in MoDC
(that were consistently positive for CD23) and in monocytes, when
donors bearing signi®cant amounts of CD23 were tested (S. Kraft,
unpublished observations). This mechanism, however, may not be
relevant for the cells used in this study: First, in contrast to Ten et al
we used monocytes and Langerhans cells from donors showing
FceRI expression and no or negligable CD23 levels. These cells
consistently showed NF-kB activation upon stimulation by IgE and
anti-IgE. Second, it has been shown that FceRI and not CD23/
FceRII represents the IgE-binding structure on human monocytes
(Maurer et al, 1994) and Langerhans cells (Rieger et al, 1992).
Third, Ten et al (1999) used U937 monocytic cells transfected with
FceRI to determine its role in IgE/anti-IgE induced NF-kB
activation; however, in these experiments IgE/anti-IgE complexes
failed to induce the phosphorylation of FceRIg, which is manda-
tory for downstream signal transduction, suggesting a defect in the
upstream signal transduction machinery in these transfected cells.
Fourth, using monoclonal, noncrossreactive antibodies, we clearly
demonstrated that FceRI is able to induce NF-kB DNA binding
both in monocytes and in MoDC. Taken together, we propose a
major role for FceRI in NF-kB induction in human APC.
The activation of NF-kB via cross-linking of FceRI was
preceded by IkB-a serine phosphorylation, whereas its tyrosine
phosphorylation was not detected (S. Kraft, unpublished observ-
ations). In contrast to targeting IkB-b this could lead to self-
limiting responses in the absence of prolonged stimulation, because
Table I. FceRI ligation on monocytes induces synthesis of TNF-a and MCP-1, which are sensitive to NAC and TPCKa
Stimulation:
Inhibitor:
nil
nil
IgE/anti-IgE
nil
IgE/anti-IgE
NAC
IgE/anti-IgE
NAC
% positive MCP-1 11.90 6 3.03 31.88 6 7.31* 4.39 6 0.85** 1.87 6 0.50**
% positive TNF-a 7.29 6 1.95 19.11 6 3.64** 6.28 6 2.06** 3.86 6 1.03**
rFI MCP-1 0.78 6 0.20 3.60 6 1.06* 0.37 6 0.11** 0.17 6 0.08**
rFI TNF-a 0.96 6 0.28 1.89 6 0.29* 0.87 6 0.32** 0.21 6 0.08**
aMonocytes were left unstimulated or loaded with IgE for 60 min, washed, and then stimulated with anti-IgE antibody in the presence or absence of NAC or TPCK.
After culture for 18 h using GolgiPlug, intracellular cytokine expression was detected by staining of saponin-permeabilized cells using PE-labeled antibodies against MCP-1
or TNF-a followed by ¯ow cytometric analysis. Values for percentage positive cells and rFI values 6 SEM are shown (n = 6). Statistical analysis was performed using
Wilcoxons' test (*p < 0.1, **p < 0.05). IgE/anti-IgE stimulated cells without inhibitors were tested against unstimulated cells. IgE/anti-IgE stimulated cells with inhibitors
were tested against IgE/anti-IgE stimulated cells without inhibitors.
Figure 5. FceRI ligation on monocytes and MoDC induces serine
phosphorylation of IkB-a followed by its degradation, but not
IkB-b degradation. Cells were loaded with IgE, washed, and then
stimulated with anti-IgE antibody for various time periods. After cell
lysis, immunoblotting was performed using anti-IkB-a-phosphoserine
(A), anti-IkB-a (B), and (shown for monocytes) IkB-b (C) antibodies.
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NF-kB activation induces the resynthesis of IkB-a molecules
(Baeuerle and Henkel, 1994). The kinase(s) inducing phosphoryl-
ation of IkB-a serine residues in our system are unknown, but this
process may be induced by the IKK signalosome (Karin and Ben-
Neriah, 2000). Alternatively, p90rsk, which lies downstream of
MAP kinase in the well-characterized Ras-Raf-MEK-MAP kinase
pathway, may be involved (Schouten et al, 1997); however, in
other experiments aimed to examine the role of p90rsk activity in
inducing IkB-a phosphorylation, we failed to observe an inhibition
of FceRI-induced NF-kB activation in the presence of PD 098059
(S. Kraft, unpublished observations), a speci®c MEK1 inhibitor
(Dudley et al, 1995), implying that the IKK signalosome may be
involved. Recent studies in murine mast cells described a regulatory
role for the kinase Akt in FceRI-mediated activation of transcrip-
tion factors like AP-1, NF-AT, and NF-kB (Kitaura et al, 2000),
suggesting Akt as a candidate linking FceRI to IKK/IkB-a.
In a mouse model, it has been shown that NF-kB plays a crucial
role in the pathogenesis of asthma as a regulator of IL-5, eotaxin,
and MIP-1 expression (Yang et al, 1998). Similarly, our data using
human APC imply NF-kB as an important regulator in the FceRI-
induced activation of these cells as supported by the suppressive
effect of the antioxidant NAC and the proteasome inhibitor TPCK.
Their use led to the suppression of FceRI-induced expression and
release of MCP-1 and TNF-a, indicating their potential value for
therapeutic strategies in atopic diseases. Interestingly, NAC showed
a higher ef®ciency in suppressing MCP-1 and TNF-a secretion in
DC when compared with monocytes. This could be due to a
differentiation-induced alteration of the expression and/or activity
of signaling molecules leading to NF-kB activation. In addition, it
is likely that MCP-1 and TNF-a transcription might be activated
by NF-kB in cooperation with other transcription factors such as
AP-1 (Kitaura et al, 2000), which has been shown to be activated
upon antioxidants (Munoz et al, 1996). AP-1 possibly might
contribute to FceRI-mediated cytokine transcription to a bigger
extent in MoDC compared with monocytes.
In summary, we showed that FceRI ligation on APC provides a
stimulus leading to NF-kB activation. Besides FceRI-mediated
antigen focusing, this could represent a crucial mechanism by
which FceRI-bearing APC could in¯uence in¯ammatory reactions
in atopic disease by upregulation of proin¯ammatory cytokines and
chemokines, as shown here for TNF-a and MCP-1.
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